The Supreme Court commences its December session today, hearing oral arguments in two pivotal cases: FDA v. Wages and White Lion Investments, LLC and U.S. v. Miller. These proceedings carry significant implications for both regulatory agencies and financial practices across the United States.
The first case, FDA v. Wages and White Lion Investments, LLC, centers on the Food and Drug Administration’s 2021 decision to reject applications from two companies seeking to market fruit and candy flavored vape liquids. The FDA contended that these products pose a risk to youth, a matter that has stirred considerable debate over the balance between public health and commercial freedom.
Following this, the justices will delve into U.S. v. Miller, which touches on financial law, specifically the question of whether payments made to the IRS shortly before a debtor files for bankruptcy should be returned. The outcome could set a precedent affecting the treatment of similar financial transactions amidst bankruptcy proceedings.
These cases highlight the diverse legal issues the Court is set to address during this session, reflecting the complexities and nuances of regulatory and financial regulations. Legal professionals and stakeholders in related sectors will be closely analyzing the proceedings to gauge the Court’s stance and potential impact on their operations.